I am very proud that the UCI Diabetes Center has become the fastest growing diabetes center on the West Coast since we established our center two years ago. We are dedicated to preventing diabetes, providing cutting-edge care and advancing science to find a cure. Recently, our researchers have made exciting discoveries that may be used toward better prevention and treatment of diabetes in the future, including novel compounds for potential prevention of type 1 diabetes.
In addition, our endocrinology fellowship training program has become one of the most sought after endocrinology training programs in the western United States. This year alone over one hundred and fifty physicians applied and competed for two training spots
Our clinic was recently recognized as the top diabetes center with the best patient outcomes in a survey among 16 diabetes centers across the United States, including the best average patient hemoglobin A1C! We are also making strides in our education and community outreach programs.
I want to congratulate the center’s faculty and staff, and our patients for making this type of recognition possible.
Ping H. Wang, MD
Director, UC Irvine Diabetes Center
Prof. of Medicine, Physiology & Biophysics, & Experimental Pathology
Chief, Division of Endocrinology, UCI Medical Center
Co-Director, UCI Stem Cell Training Program
About Ping H. Wang, MD
Dr. Ping Wang is a Harvard-trained endocrinologist and received his diabetes training at the Joslin Diabetes Center in Boston. Dr. Wang joined UC Irvine’s School of Medicine faculty as a Professor of Medicine and also serves as Chief of Endocrinology, Diabetes and Metabolism at UC Irvine Medical Center. As the Director of the UC Irvine Diabetes Center, he is responsible for the overall development of the diabetes research and patient care programs at UC Irvine Health. Ping is also an active researcher in the area of diabetes complications and heart disease. In his laboratory, located in the Sue & Bill Gross Stem Cell Research Center, Dr. Wang aims to define the molecular mechanisms of diabetic heart complications. In addition to his administrative, clinical, and research duties, Ping also participates in national clinical and research programs. For example, he has served as grant reviewer for the National Institutes of Health, UK Wellcome Trust, American Heart Association, etc. He has sat on the review panel for American College of Physicians on diabetes standards of care. He and his colleagues have published numerous research papers and commentary articles in leading journals.